Procter & Gamble Health Ltd (PGHL) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 346859, "name": "P & G Health Ltd", "stock_name": "P & G Health Ltd", "full_name": "Procter & Gamble Health Ltd", "name_url": "stocks-analysis/p-g-health", "exchange": 0, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "5,361.90", "chg": 168.15, "chgp": "3.24%", "dir": 1, "prev_price": "5,193.75", "mcapval": "8,900.42 Cr", "mcap": "Small Cap", "scripcode": 500126, "symbol": "PGHL", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE199A01012", "curr_date": "Feb 09", "curr_time": "", "bse_nse_vol": "25.47 k", "exc_status": "Active", "traded_date": "Feb 09, 2026", "traded_date_str": "2026 02 09", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/p-g-health-346859-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Are Procter & Gamble Health Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-procter-gamble-health-ltd-latest-results-good-or-bad-3824810", "imagepath": "", "date": "2026-02-06 19:22:36", "description": "Procter & Gamble Health Ltd's Q3 FY26 results present a complex picture of financial performance, characterized by strong revenue growth but significant challenges in profitability. The company reported net sales of ₹373.86 crores, reflecting a robust year-on-year growth of 20.69% and a sequential increase of 15.06%. This indicates a strong demand for its pharmaceutical and consumer health products.\n\nHowever, the net profit for the same quarter was ₹77.59 crores, which represents a decline of 14.60% year-on-year and a decrease of 12.37% compared to the previous quarter. This decline is attributed to margin compression and rising tax expenses, highlighting operational challenges that the company faces. The profit after tax (PAT) margin fell to 20.75%, down from 27.25% in the prior quarter, indicating a significant contraction in profitability.\n\nOperating profit before depreciation, interest, and tax (excludi..." }, { "title": "Procter & Gamble Health Q3 FY26: Profit Decline Overshadows Revenue Growth", "link": "https://www.marketsmojo.com/news/result-analysis/procter-gamble-health-q3-fy26-profit-decline-overshadows-revenue-growth-3824742", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ProcterGambleHe_quaterlyResult_3824742.png", "date": "2026-02-06 17:17:29", "description": "Procter & Gamble Health Ltd. reported a mixed performance for Q3 FY26 (October-December 2025), with net profit declining 12.37% quarter-on-quarter to ₹77.59 crores despite revenue growth of 15.06%. The pharma major, with a market capitalisation of ₹8,602 crores, continues to trade at premium valuations even as operational challenges persist. The stock has declined 13.27% over the past three months and currently trades at ₹5,193.95, down 1.24% from the previous close." }, { "title": "Procter & Gamble Health Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-is-rated-sell-3811207", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ProcterGambleHe_mojoScore_3811207.png", "date": "2026-01-30 10:10:03", "description": "Procter & Gamble Health Ltd is rated Sell by MarketsMOJO, with this rating last updated on 07 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 30 January 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Procter & Gamble Health Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-is-rated-sell-3794173", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ProcterGambleHe_mojoScore_3794173.png", "date": "2026-01-19 10:10:03", "description": "Procter & Gamble Health Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 January 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Why is Procter & Gamble Health Ltd falling/rising?", "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-procter-gamble-health-ltd-fallingrising-3790339", "imagepath": "", "date": "2026-01-13 01:05:41", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>Over the past week, Procter & Gamble Health Ltd’s shares have fallen sharply by 6.8%, significantly underperforming the Sensex’s modest 1.83% decline during the same period. This downward momentum has persisted for five consecutive trading sessions, signalling sustained selling pressure. The stock also underperformed its sector by 1.87% on the day, touching an intraday low of ₹5,400, which represents a 3.09% drop from the previous close. Notably, the weighted average price indicates that a larger volume of shares traded closer to the day’s low, suggesting that sellers dominated the session.</p>\n<p>Technical indicators reinforce this bearish sentiment, with the stock currently trading below all key moving averages, including the..." }, { "title": "Procter & Gamble Health Ltd Falls 2.50%: Mixed Technicals and Valuation Weigh on Stock", "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-falls-250-mixed-technicals-and-valuation-weigh-on-stock-3788664", "imagepath": "", "date": "2026-01-11 09:00:07", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>5 Jan:</strong> Stock opens strong at Rs.5,837.95 (+2.16%) despite Sensex decline</p>\n <p><strong>7 Jan:</strong> Death Cross formation signals potential bearish trend</p>\n <p><strong>8 Jan:</strong> Downgrade to Sell rating amid mixed technicals and valuation concerns</p>\n <p><strong>9 Jan:</strong> Week closes at Rs.5,571.90 (-2.20%) with continued downward pressure</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.5,714.50</div></div>\n <div class=\"stat-item\"><div class=\"stat-lab..." }, { "title": "Procter & Gamble Health Ltd Downgraded to Sell Amid Mixed Technicals and Valuation Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-downgraded-to-sell-amid-mixed-technicals-and-valuation-concerns-3785075", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ProcterGambleHe_mojoScore_3785075.png", "date": "2026-01-08 08:08:19", "description": "Procter & Gamble Health Ltd has seen its investment rating downgraded from Hold to Sell as of 7 January 2026, driven primarily by a deterioration in technical indicators and valuation metrics. Despite a solid long-term return relative to the Sensex, the company’s flat recent financial performance and expensive valuation have raised concerns among analysts, prompting a reassessment of its investment appeal." }, { "title": "Procter & Gamble Health Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-faces-technical-momentum-shift-amid-mixed-indicator-signals-3785070", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ProcterGambleHe_technicaldot_3785070.png", "date": "2026-01-08 08:06:04", "description": "Procter & Gamble Health Ltd (P&G Health) has experienced a subtle shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend as of early January 2026. Despite a strong long-term performance relative to the Sensex, recent technical indicators suggest caution for investors as mixed signals emerge from key momentum and trend-following tools." }, { "title": "Procter & Gamble Health Ltd Forms Death Cross, Signalling Potential Bearish Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-forms-death-cross-signalling-potential-bearish-trend-3784839", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ProcterGambleHe_dealthcross_3784839.png", "date": "2026-01-07 18:01:19", "description": "Procter & Gamble Health Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development suggests a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium-term momentum and raising concerns about long-term weakness in the Pharmaceuticals & Biotechnology sector player." } ], "total": 135, "sid": "346859", "stock_news_url": "https://www.marketsmojo.com/news/procter-gamble-health-346859" }, "announcements": [ { "caption": "Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health Limited", "datetime": "06-Feb-2026", "details": "Dear Sir Please find attached communication in respect of deduction of TDS on the amount of dividend income from declaration of interim dividend for the Financial year 2025-26.", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On February 6 2026", "datetime": "06-Feb-2026", "details": "We are enclosing herewith the following: a. Unaudited Financial Results; b. Limited Review Report in respect of the Unaudited Financial Results furnished by Statutory Auditors of the Company. Further we are pleased to inform you that the Board of Directors of the Company at its meeting held today inter alia have declared an Interim Dividend for the Financial Year 2025-26 of Rs. 160 per Equity Share (including a one-time special dividend of Rs. 50 per Equity Share). The dividend shall be paid on or before March 4 2026.", "source": "BSE" }, { "caption": "Corporate Action-Board approves Dividend", "datetime": "06-Feb-2026", "details": "Board approves interim dividend of Rs. 160 (including one time special dividend of Rs. 50) per share.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Procter & Gamble Health Ltd has declared <strong>450%</strong> dividend, ex-date: 22 Aug 25", "dt": "2025-08-22", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

5 Jan: Stock opens strong at Rs.5,837.95 (+2.16%) despite Sensex decline

7 Jan: Death Cross formation signals potential bearish trend

8 Jan: Downgrade to Sell rating amid mixed technicals and valuation concerns

9 Jan: Week closes at Rs.5,571.90 (-2.20%) with continued downward pressure

Week Open

Rs.5,714.50

Read full news article

Procter & Gamble Health Ltd Downgraded to Sell Amid Mixed Technicals and Valuation Concerns

2026-01-08 08:08:19

Procter & Gamble Health Ltd has seen its investment rating downgraded from Hold to Sell as of 7 January 2026, driven primarily by a deterioration in technical indicators and valuation metrics. Despite a solid long-term return relative to the Sensex, the company’s flat recent financial performance and expensive valuation have raised concerns among analysts, prompting a reassessment of its investment appeal.

Read full news article

Procter & Gamble Health Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals

2026-01-08 08:06:04

Procter & Gamble Health Ltd (P&G Health) has experienced a subtle shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend as of early January 2026. Despite a strong long-term performance relative to the Sensex, recent technical indicators suggest caution for investors as mixed signals emerge from key momentum and trend-following tools.

Read full news article

Procter & Gamble Health Ltd Forms Death Cross, Signalling Potential Bearish Trend

2026-01-07 18:01:19

Procter & Gamble Health Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development suggests a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium-term momentum and raising concerns about long-term weakness in the Pharmaceuticals & Biotechnology sector player.

Read full news article